In this context, the LCHP+3 diet could be a low-cost, accessible, non-drug intervention with quick glucose-lowering and fluctuation-suppressing effects for patients, especially those who need to limit insulin secretion (e.g., diabetes and cancer patients) or those who cannot tolerate other drug treatments. Here, INS is linked to cancer.